ABOUT US
We are building a world-class 200-bed hospital and neuroscience research institute in Ukambani, Kenya — combining clinical excellence, precision medicine, and digital innovation to tackle the Non-Communicable Disease (NCD) crisis.
Leadership
The journey from PAIN to PASSION to PRACTICE has shaped my vision of building a Word-Class Hospital in Ukambani, Kenya. At age 10, I came home to find my mother lying under a tree, groaning in pain. The PAIN of witnessing my mother's suffering ignited a deep PASSION within me to advocate for the NEEDS of low resource & vulnerable populations. This led to my resolve of pursuing medicine & public health with the drive of making a meaningful impact in the lives of others. My personal experience has fueled my commitment to address Africa`s Health Care challenges with the aim of promoting growth of a healthy, resilient and innovative industry. Join me on this transformative journey as we work towards a future where quality tertiary healthcare is accessible to ALL in the African Continent.
Timothy Muia,
MD, MPH
Board of Directors
-
Dr. Marion Bergman, MD-Board Member, John Hopkins
-
Ms. Nyawira Njeru-Africa Regional Director, Hologic, Inc
-
Dr. Christina Hoven-Director, Child Psychiatric Epidemiology, Columbia University
-
Mr. Les Funtleyder-CEO, Applied Therapeutics
-
Prof. John Winkleman-Board Member, Mount Sinai Hospital, Prof. Columbia University
-
Mr. Arthur Gianelli-President, Brooklyn One Health
-
Mr. Steve Roy Goodman, JD-Lawyer
-
Dr. Matilu Mwau-Director. KEMRI
Advisory Board
-
Donna Boles-Rt. Senior VP HR, BD
-
Dr. Caroline Popper-President, Popper&Co
-
Jennifer Luray-Senior VP Research! America
-
Mr. Gary Cohen-CEO, MNHI
-
Mr. Edward Ludwig-Retired CEO, BD
-
Prof Zohn-Professor, Columbia University
Our Strategic Approach
J.P. Muia Medicine is built on a long-term, impact-driven strategy to transform access to high-quality tertiary healthcare in Africa, starting with the Ukambani region of Kenya. Our strategy integrates clinical excellence, data-driven decision-making, research leadership, and equitable access to care.
We address the growing burden of non-communicable diseases (NCDs) through a scalable, sustainable, and patient-centered healthcare model that bridges clinical services, research, and public health policy.
1. Integrated Tertiary Care Hub
We are developing a world-class tertiary hospital model that brings specialized care closer to underserved populations. This integrated hub will deliver advanced services in cardiology, oncology, neurology, psychiatry, nephrology, trauma care, and chronic disease management under one coordinated system.
2. Phased Growth & Sustainability
Our expansion follows a structured, multi-phase roadmap:
-
Phase 1: Foundational clinical services and diagnostics
-
Phase 2: Specialized services, trauma care, and telemedicine integration
-
Phase 3: Establishment of a neurobehavioral and genomic research center
-
Phase 4: Regional expansion, innovation, and global collaboration
This phased approach ensures operational sustainability, workforce readiness, and financial resilience.
3. Technology-Enabled Care Delivery
We leverage digital health solutions, telemedicine, and data platforms to improve early diagnosis, continuity of care, and long-term management of chronic conditions—especially for rural and low-income populations.
4. Policy & Health Systems Impact
J.P. Muia Medicine actively engages with policymakers, insurers, donors, and academic institutions to influence healthcare system design, promote evidence-based policy, and strengthen national and regional health systems.
5. Equity & Community-Centered Access
Equitable access is central to our strategy. We aim to reduce geographic, financial, and workforce disparities by embedding community outreach, prevention programs, and culturally appropriate care into our service model.
Research & Innovation
Research and innovation are foundational to J.P. Muia Medicine’s mission. We are committed to building strong African research infrastructure that addresses the continent’s unique disease burden, genetic diversity, and health system challenges.
Ukambani Neurological Research Institute (UNRI)
At the heart of our innovation agenda is the Ukambani Neurological Research Institute (UNRI)—a dedicated center focused on neurobehavioral science, genomics, and precision medicine for Africa.
UNRI was conceived to address:
-
Underrepresentation of African populations in global health data
-
Limited neuroscience research capacity on the continent
-
High and rising burden of neurological and mental health conditions
-
Brain drain of African researchers and clinicians
Key Research Focus Areas
1. Neurobehavioral & Mental Health Research
-
Neurological disorders
-
Mental health conditions
-
Brain–behavior relationships
-
Community-based mental health interventions
2. Genomic & Precision Medicine
-
Inclusive genomic science representing African ancestry
-
Africa-specific disease risk profiling
-
Personalized treatment approaches for NCDs
3. NCD Surveillance & Data Systems
-
Population-level disease surveillance
-
Longitudinal health data infrastructure
-
Evidence generation for better clinical and policy decisions
4. Translational & Clinical Research
-
Bridging laboratory discoveries with bedside care
-
Improving diagnostics, treatment protocols, and patient outcomes
-
Embedding research directly into clinical practice
Innovation Through Collaboration
We actively collaborate with:
-
Global academic institutions
-
Public health agencies
-
Philanthropic organizations
-
Policy bodies and donors
These partnerships ensure ethical research, data equity, capacity building, and global impact—while ensuring African communities directly benefit from the knowledge generated.
Impact of Our Research Agenda
Through strong research and innovation ecosystems, J.P. Muia Medicine aims to:
-
Improve clinical outcomes and quality of care
-
Empower local communities through knowledge and participation
-
Build Africa-led data for global health equity
-
Position Kenya and the Ukambani region as a center of excellence in neuroscience and NCD research